Literature DB >> 30879919

Ethical and Policy Considerations for Genomic Testing in Pediatric Research: The Path Toward Disclosing Individual Research Results.

Craig S Wong1, Amy J Kogon2, Bradley A Warady3, Susan L Furth2, John D Lantos4, Benjamin S Wilfond5.   

Abstract

DNA is now commonly collected in clinical research either for immediate genomic analyses or stored for future studies. Many genomic studies were previously designed without awareness of the ethical issues that might arise regarding the disclosure of genomic test results. At the start of the Chronic Kidney Disease in Children (CKiD) Cohort Study in 2004, we did not foresee the advent of genomic technology or the associated ethical issues pertaining to genetic research in children. Recent genomic studies and ancillary proposals using genomic technology stimulated the CKiD investigators to reassess the current ethical and policy environment pertaining to genomic testing and results disclosure. We consider the issues pertaining to next generation sequencing and individual results disclosure that may guide current and future research practices.
Copyright © 2019 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DNA collection; Genomics; adolescent; children; chronic kidney disease (CKD); disclosure; ethics; genetic disease; human subjects protections; incidental finding; informed consent; pediatric; review

Mesh:

Year:  2019        PMID: 30879919      PMCID: PMC6548468          DOI: 10.1053/j.ajkd.2019.01.020

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  40 in total

Review 1.  Genetic test evaluation: information needs of clinicians, policy makers, and the public.

Authors:  Wylie Burke; David Atkins; Marta Gwinn; Alan Guttmacher; James Haddow; Joseph Lau; Glenn Palomaki; Nancy Press; C Sue Richards; Louise Wideroff; Georgia L Wiesner
Journal:  Am J Epidemiol       Date:  2002-08-15       Impact factor: 4.897

Review 2.  Ethical, legal, and social implications of genomic medicine.

Authors:  Ellen Wright Clayton
Journal:  N Engl J Med       Date:  2003-08-07       Impact factor: 91.245

3.  Disclosing individual genetic results to research participants.

Authors:  Vardit Ravitsky; Benjamin S Wilfond
Journal:  Am J Bioeth       Date:  2006 Nov-Dec       Impact factor: 11.229

4.  Ethics. Identifiability in genomic research.

Authors:  William W Lowrance; Francis S Collins
Journal:  Science       Date:  2007-08-03       Impact factor: 47.728

5.  The Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) study: objectives, design, and methodology.

Authors:  Uwe Querfeld; Ali Anarat; Aysun K Bayazit; Aysin S Bakkaloglu; Yelda Bilginer; Salim Caliskan; Mahmut Civilibal; Anke Doyon; Ali Duzova; Daniela Kracht; Mieczyslaw Litwin; Anette Melk; Sevgi Mir; Betül Sözeri; Rukshana Shroff; René Zeller; Elke Wühl; Franz Schaefer
Journal:  Clin J Am Soc Nephrol       Date:  2010-06-24       Impact factor: 8.237

6.  Reporting genetic results in research studies: summary and recommendations of an NHLBI working group.

Authors:  Ebony B Bookman; Aleisha A Langehorne; John H Eckfeldt; Kathleen C Glass; Gail P Jarvik; Michael Klag; Greg Koski; Arno Motulsky; Benjamin Wilfond; Teri A Manolio; Richard R Fabsitz; Russell V Luepker
Journal:  Am J Med Genet A       Date:  2006-05-15       Impact factor: 2.802

7.  Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group.

Authors:  Richard R Fabsitz; Amy McGuire; Richard R Sharp; Mona Puggal; Laura M Beskow; Leslie G Biesecker; Ebony Bookman; Wylie Burke; Esteban Gonzalez Burchard; George Church; Ellen Wright Clayton; John H Eckfeldt; Conrad V Fernandez; Rebecca Fisher; Stephanie M Fullerton; Stacey Gabriel; Francine Gachupin; Cynthia James; Gail P Jarvik; Rick Kittles; Jennifer R Leib; Christopher O'Donnell; P Pearl O'Rourke; Laura Lyman Rodriguez; Sheri D Schully; Alan R Shuldiner; Rebecca K F Sze; Joseph V Thakuria; Susan M Wolf; Gregory L Burke
Journal:  Circ Cardiovasc Genet       Date:  2010-12

8.  HNF1B and PAX2 mutations are a common cause of renal hypodysplasia in the CKiD cohort.

Authors:  Rosemary Thomas; Simone Sanna-Cherchi; Bradley A Warady; Susan L Furth; Frederick J Kaskel; Ali G Gharavi
Journal:  Pediatr Nephrol       Date:  2011-03-05       Impact factor: 3.714

9.  Pediatric biobanks: approaching informed consent for continuing research after children grow up.

Authors:  Aaron J Goldenberg; Sara Chandros Hull; Jeffrey R Botkin; Benjamin S Wilfond
Journal:  J Pediatr       Date:  2009-10       Impact factor: 4.406

10.  Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study.

Authors:  Susan L Furth; Stephen R Cole; Marva Moxey-Mims; Frederick Kaskel; Robert Mak; George Schwartz; Craig Wong; Alvaro Muñoz; Bradley A Warady
Journal:  Clin J Am Soc Nephrol       Date:  2006-07-19       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.